Mn Services Vermogensbeheer B.V. Regeneron Pharmaceuticals, Inc. Transaction History
Mn Services Vermogensbeheer B.V.
- $12.9 Billion
- Q1 2025
A detailed history of Mn Services Vermogensbeheer B.V. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 39,600 shares of REGN stock, worth $23.2 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
39,600
Previous 42,500
6.82%
Holding current value
$23.2 Million
Previous $30.3 Million
17.04%
% of portfolio
0.19%
Previous 0.2%
Shares
26 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.44 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.95 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.13 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.77 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...